Specifications TableSubject area*chemistry*More specific subject area*natural products*Type of data*Figure*How data was acquired*NMR spectroscopy: JEOL A400; ESIMS: Thermo Fisher Scientific LTQ Orbitrap XL mass spectrometer.*Data format*Raw and analyzed*Experimental factors*The undescribed sulfated purine alkaloids were purified by column chromatography.*Experimental features*The isolated compounds were characterized by ESIMS and NMR spectroscopy*Data source location*Higashi-Hiroshima, Japan*Data accessibility*Data are available with this article*Related research article*Y. Uyama, E. Ohta, Y. Harauchi, T. Nehira, H. Ômura, H. Kawachi, A. Imamura-Jinda, M. M. Uy, S. Ohta, Rare sulfated purine alkaloid glycosides from Bruchidius dorsalis pupal case, Phytochemistry Letters 35 (2020) 10--14.***Value of the Data**•The data presents NMR data and ESIMS data of newly isolated sulfated purine alkaloids and could be used by other researchers.•The provided information on the spectroscopic data of sulfated purine alkaloids could be useful for the analysis of spectra and determination of the structure of other sulfated purine alkaloids.•This data can serve as a benchmark for other researchers to elucidate the structures of sulfated purine alkaloids.

1. Data {#sec1}
=======

The data set presented in this article focuses on characterization of the sulfated purine alkaloids described in \[[@bib1]\]. The article provides the information on the spectroscopic data of the sulfated purine alkaloids **1**--**3** isolated from the pupal case produced by the bruchid beetle *Bruchidius dorsalis* inside the seed of *Gleditsia japonica* ([Fig. 1](#fig1){ref-type="fig"}). The ^1^H NMR spectra of **1**--**3** are shown in [Fig. 2a](#fig2a){ref-type="fig"}, [Fig. 3a](#fig3a){ref-type="fig"}, [Fig. 4a](#fig4a){ref-type="fig"}, respectively. The ^13^C NMR and DEPT spectra of **1**--**3** are shown in [Fig. 2b](#fig2b){ref-type="fig"}, [Fig. 3b](#fig3b){ref-type="fig"}, [Fig. 4b](#fig4b){ref-type="fig"}, respectively. 2D ^1^H--^1^H COSY spectra of **1**--**3** are shown in [Fig. 2c](#fig2c){ref-type="fig"}, [Fig. 3c](#fig3c){ref-type="fig"}, [Fig. 4c](#fig4c){ref-type="fig"}, respectively. 2D ^1^H--^1^H NOESY spectra of **1**--**3** are shown in [Fig. 2d](#fig2d){ref-type="fig"}, [Fig. 3d](#fig3d){ref-type="fig"}, [Fig. 4d](#fig4d){ref-type="fig"}, respectively. 2D ^1^H--^13^C heteronuclear single quantum coherence (HSQC) spectra of **1**--**3** are shown in [Fig. 2e](#fig2e){ref-type="fig"}, [Fig. 3e](#fig3e){ref-type="fig"}, [Fig. 4e](#fig4e){ref-type="fig"}, respectively. 2D ^1^H--^13^C heteronuclear multiple-bond correlation (HMBC) spectra of **1**--**3** are shown in [Fig. 2f](#fig2f){ref-type="fig"}, [Fig. 3f](#fig3f){ref-type="fig"}, [Fig. 4f](#fig4f){ref-type="fig"}, respectively. ESIMS data of **1**--**3** are shown in [Fig. 2g](#fig2g){ref-type="fig"}, [Fig. 3g](#fig3g){ref-type="fig"}, [Fig. 4g](#fig4g){ref-type="fig"}, respectively. Analyses of the spectra of **1**--**3** are described in the research article \[[@bib1]\]. It has been reported that **3** inhibited starfish blastulation during embryonic development \[[@bib1]\].Fig. 1Structures of sulfated isoguanine glycosides isolated from pupal case produced by bruchid beetle *Bruchidius dorsalis* inside *Gleditsia japonica* seeds.Fig. 1

Although some sulfated guanosine analogs, such as the kainate receptor inhibitor HF-7 \[[@bib2]\], have been isolated from the venom of spiders \[[@bib3]\], sulfated nucleoside derivatives from natural sources other than spiders are rare \[[@bib1],[@bib4]\].

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Samples {#sec2.1}
------------

Samples were isolated according to a previously reported method \[[@bib1]\].

2.2. Description of the NMR experiments {#sec2.2}
---------------------------------------

Compounds **1**--**3** were dissolved in 0.6 mL of a mixture of CD~3~OD and D~2~O (1:9). All NMR spectra were acquired using a JEOL A400 spectrometer (400 MHz for ^1^H, 100 MHz for ^13^C). NMR analysis was performed using the ALICE2 software (JEOL, Tokyo, Japan). ^1^H and ^13^C NMR chemical shifts were referenced to residual solvent peaks: *δ*~H~ 3.30 (residual CHD~2~OD) and *δ*~C~ 49.0 for CD~3~OD. HRESIMS were carried out using a Thermo Fisher Scientific LTQ Orbitrap XL mass spectrometer at the Natural Science Center for Basic Research and Development (N-BARD), Hiroshima University.

3. Sulfated isoguanine glycosides 1--3 {#sec3}
======================================

3.1. 6-Amino-7-(2,4-di-*O*-sulfo-β-[d]{.smallcaps}-glucopyranosyl)-3,7-dihydro-3-(3-methyl-2-buten-1-yl) -2H-purin-2-one (locustoside A disulfate) (**1**) {#sec3.1}
----------------------------------------------------------------------------------------------------------------------------------------------------------

1D NMR, 2D NMR, and HRESIMS spectra of the compound **1** are shown in [Fig. 2a](#fig2a){ref-type="fig"}, [Fig. 2b](#fig2b){ref-type="fig"}, [Fig. 2c](#fig2c){ref-type="fig"}, [Fig. 2d](#fig2d){ref-type="fig"}, [Fig. 2e](#fig2e){ref-type="fig"}, [Fig. 2f](#fig2f){ref-type="fig"}, [Fig. 2g](#fig2g){ref-type="fig"}a--g.Fig. 2a^1^H NMR (400 MHz, CD~3~OD--D~2~O, 1:9) of **1**.Fig. 2aFig. 2b^13^C NMR and DEPT (100 MHz, CD~3~OD--D~2~O, 1:9) of **1**.Fig. 2bFig. 2c^1^H--^1^H COSY of **1**.Fig. 2cFig. 2d^1^H--^1^H NOESY of **1**.Fig. 2dFig. 2e^1^H--^13^C HSQC of **1**.Fig. 2eFig. 2f^1^H--^13^C HMBC of **1**.Fig. 2fFig. 2g(−)HRESIMS of **1**.Fig. 2g

3.2. 6-Amino-7-(6-*O*-[d]{.smallcaps}-apio-β-[d]{.smallcaps}-furanosyl-2,4-di-*O*-sulfo-β-[d]{.smallcaps}-glucopyranosyl)-3,7-dihydro-3-\[(2Z)-4-hydroxy-3-methyl-2-buten-1-yl\])-2H-purin-2-one (saikachinoside B disulfate) (**2**) {#sec3.2}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1D NMR, 2D NMR, and HRESIMS spectra of the compound **2** are shown in [Fig. 3a](#fig3a){ref-type="fig"}, [Fig. 3b](#fig3b){ref-type="fig"}, [Fig. 3c](#fig3c){ref-type="fig"}, [Fig. 3d](#fig3d){ref-type="fig"}, [Fig. 3e](#fig3e){ref-type="fig"}, [Fig. 3f](#fig3f){ref-type="fig"}, [Fig. 3g](#fig3g){ref-type="fig"}a--g.Fig. 3a^1^H NMR (400 MHz, CD~3~OD--D~2~O, 1:9) of **2**.Fig. 3aFig. 3b^13^C NMR and DEPT (100 MHz, CD~3~OD--D~2~O, 1:9) of **2**.Fig. 3bFig. 3c^1^H--^1^H COSY of **2**.Fig. 3cFig. 3d^1^H--^1^H NOESY of **2**.Fig. 3dFig. 3e^1^H--^13^C HSQC of **2**.Fig. 3eFig. 3f^1^H--^13^C HMBC of **2**.Fig. 3fFig. 3g(−)HRESIMS of **2**.Fig. 3g

3.3. 6-Amino-3,7-dihydro-3-\[(2Z)-4-hydroxy-3-methyl-2-buten-1-yl\]-7-(2,4,6-tri-*O*-sulfo-β-[d]{.smallcaps}-glucopyranosyl)-2H-purin-2-one (saikachinoside A trisulfate) (**3**) {#sec3.3}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1D NMR, 2D NMR, and HRESIMS spectra of the compound **3** are shown in [Fig. 4a](#fig4a){ref-type="fig"}, [Fig. 4b](#fig4b){ref-type="fig"}, [Fig. 4c](#fig4c){ref-type="fig"}, [Fig. 4d](#fig4d){ref-type="fig"}, [Fig. 4e](#fig4e){ref-type="fig"}, [Fig. 4f](#fig4f){ref-type="fig"}, [Fig. 4g](#fig4g){ref-type="fig"}a--g.Fig. 4a^1^H NMR (400 MHz, CD~3~OD--D~2~O, 1:9) of **3**.Fig. 4aFig. 4b^13^C NMR and DEPT (100 MHz, CD~3~OD--D~2~O, 1:9) of **3**.Fig. 4bFig. 4c^1^H--^1^H COSY of **3**.Fig. 4cFig. 4d^1^H--^1^H NOESY of **3**.Fig. 4dFig. 4e^1^H--^13^C HSQC of **3**.Fig. 4eFig. 4f^1^H--^13^C HMBC of **3**.Fig. 4fFig. 4g(−)HRESIMS of **3**.Fig. 4g
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